Skip to main content
padlock icon - secure page this page is secure
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 18, Number 4, May 2018

Articles

Free Content Graphical Abstracts
pp. i-v(5)
Author: Haber, M.

Favourites:
ADD

Free Content Meet Our Editorial Board Member
pp. 305-305(1)
Author: Haber, M.

Favourites:
ADD

Review article

Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer
pp. 306-327(22)
Authors: Singla, Heena; Munshi, Anjana; Banipal, Raja P. S.; Kumar, Vinod

Favourites:
ADD

Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy
pp. 328-336(9)
Authors: Eyvazi, Shirin; Kazemi, Bahram; Dastmalchi, Siavoush; Bandehpour, Mojgan

Favourites:
ADD

Synthetic Lethality: From Research to Precision Cancer Nanomedicine
pp. 337-346(10)
Authors: Gupta, Anuradha; Ahmad, Anas; Dar, Aqib I.; Khan, Rehan

Favourites:
ADD

Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy
pp. 347-354(8)
Authors: Wang, Xinyi; Zhang, Haiyang; Yang, Haiou; Bai, Ming; Ning, Tao; Li, Shuang; Li, Jialu; Deng, Ting; Ying, Guoguang; Ba, Yi

Favourites:
ADD

The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations
pp. 355-364(10)
Authors: Collins, Dearbhaile C.; Chenard-Poirier, Maxime; Lopez, Juanita S.

Favourites:
ADD

Research article

Chemosensitizing Activity of Histone Deacetylases Inhibitory Cyclic Hydroxamic Acids for Combination Chemotherapy of Lymphatic Leukemia
pp. 365-371(7)
Authors: Mishchenko, Denis V.; Neganova, Margarita E.; Klimanova, Elena N.; Sashenkova, Tatyana E.; Klochkov, Sergey G.; Shevtsova, Elena F.; Vystorop, Igor V.; Tarasov, Vadim V.; Chubarev, Vladimir N.; Samsonova, Anna N.; Ashraf, Ghulam M.; Barreto, George; Yarla, Nagendra Sastry; Aliev, Gjumrakch

Favourites:
ADD
Favourites:
ADD

FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer
pp. 382-389(8)
Authors: Wu, Jiali; Liu, Peng; Tang, Hailin; Shuang, Zeyu; Qiu, Qingsheng; Zhang, Lijuan; Song, Cailu; Liu, Lingrui; Xie, Xiaoming; Xiao, Xiangsheng

Favourites:
ADD

Neoisoliquiritigenin Inhibits Tumor Progression by Targeting GRP78-β-catenin Signaling in Breast Cancer
pp. 390-399(10)
Authors: Tang, Hailin; Peng, Fu; Huang, Xiaojia; Xie, Xinhua; Chen, Bo; Shen, Jiangang; Gao, Fei; You, Jieshu; Xie, Xiaoming; Chen, Jianping

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more